This document discusses the use and impact of EULabCap monitoring in Austria. It notes that unlike many EU countries, Austria did not require clinical microbiology laboratories to be licensed or obtain biosafety authorization, and there was no monitoring of diagnostic testing guidelines for key diseases. Contribution of national reference laboratories to national surveillance varied by disease and was below the EU average. Molecular typing data on pilot pathogens were no longer reported to the EU surveillance database and antimicrobial resistance characterization was only performed upon request, not as part of monitoring surveys. Overall compliance with EU standards was lower than most other EU nations.

1. Austrian Agency for Health and Food Safety www.ages.at
Franz Allerberger , NMFP Austria
(15 min)
Use of and impact of
EULabCap monitoring
in Austria

2. www.ages.at

3. www.ages.at 3

4. www.ages.at
open
access

5. www.ages.at 5
open
access !

6. www.ages.at
Individual country report - NOT open access

7. www.ages.at
https://www.google.at/search?q=change+model+denial+resistance+exploration+commitment&safe=strict&dcr=0&tbm=isch&source=iu&ictx=
1&fir=tU4NxRQ7JXmIyM%253A%252CXpdCC4rP2h9NTM%252C_&usg=__FeLTPPVA_NivkwtqBn-
ogYaCcB8%3D&sa=X&ved=0ahUKEwic2YjBrZbYAhVM2aQKHcV8Bl8Q9QEIQzAD#imgrc=hfT6Xpr1RrOi7M:&spf=1513696138293

8. www.ages.at
Individual country report - NOT open access

9. www.ages.at 9
Open access!

10. www.ages.at
Individual country report - NOT open access

11. www.ages.at
KRANKENANSTALT
mikrobiologische
Untersuchungen im Jahr 2016 Belegstage im Jahr 2016 Kommentar
101 253 46.800
103
104 3.781 520.573
105 18 21.250
106 30 33.021
107 2.086 304.898
108 29 33.719UKH
110
112
113 0 147.004Reha-Zentrum
116 432 37.710
118 18 44.490UKH
119
127 202 45.842
128 698 100.730
134 629 87.955
135
138 746 45.727KH mit chronisch-entzündlicher Darmambulanz
139 25 57.354
142 161 24.307
143 0 48.689Rehaklinik/Sonderklinik
144
145 29 46.586
146 247 52.742
147 144 65.452
149
150 4.521 511.384
151 1.101 121.589
152
153 1.078 184.802
Gesamt 16.228 2.582.624
DATA PROVIDED BY PROF. PRESTERL (Ref.-Centre for Nosocomial Infections)

12. www.ages.at
Individual country report - NOT open access

13. www.ages.at 13
https://www.bmgf.gv.at/home/Gesundheit/Krankheiten/Newsletter_Public_Health/Archi
v_2017/Nationale_Referenzzentrale_fuer_Gonokokken_-_Jahresbericht_2016

14. www.ages.at
Individual country report - NOT open access

15. www.ages.at
Individual country report - NOT open access

16. www.ages.at 16
“That’s how evaluations look just when comparing apples to pears! In the case of
2.24 Serogroup STEC: Stool samples sent to the reference center versus STEC
isolates sent to the reference center.”

17. www.ages.at 17
Individual country report - NOT open access

18. www.ages.at 18

20. For attention: Unlike the majority of EU countries, clinical microbiology
laboratories were not required by law to obtain a licencing nor biosafety
authorisation. There was no monitoring of compliance of diagnostic
testing guidelines for key diseases. Contribution of national reference
laboratories to national surveillance varied by disease and was overall
below EU average. Molecular typing data on pilot EU molecular
surveillance pathogens were no longer reported to EU surveillance
database TESSy. Antimicrobial resistance characterization for
carbapenemase- and ESBL-producing Enterobacteriaceae and methicillin-
resistant Staphylococcus aureus was performed only upon request from
diagnostic laboratories and not part of monitoring surveys.
EULabCap country profile AUSTRIA Report on 2016 data
Version 1, 19 December 2017
Individual country report - NOT open access

21. www.ages.at

22. www.ages.at 22

23. https://www.google.at/search?q=change+model+denial+resistance+exploration+commitment&safe=strict&dcr=0&tbm=isch&source=iu&ictx=
1&fir=tU4NxRQ7JXmIyM%253A%252CXpdCC4rP2h9NTM%252C_&usg=__FeLTPPVA_NivkwtqBn-
ogYaCcB8%3D&sa=X&ved=0ahUKEwic2YjBrZbYAhVM2aQKHcV8Bl8Q9QEIQzAD#imgrc=hfT6Xpr1RrOi7M:&spf=1513696138293
!